Your personal data is managed according to the French Data Protection Act and the General Data Protection Regulation of the European Union. It is used only to respond to your requests or to manage your contact information. Your rights to access, correct, oppose, delete, transfer or limit this information may be exercise according to these above-mentioned regulations.
Any claims should be addressed to our Data Production Officer: email@example.com
If, after having contacted ADVICENNE, you feel that your rights under the French Data Protection Act have not been respected, you may address any concerns to the French National Data Protection Commission CNIL: www.cnil.fr.
Since its founding in 2007, Advicenne has been dedicated to developing and commercializing innovative treatments that address unmet medical needs in the area of nephrology. Our lead drug candidate, ADV7103, is in late-stage clinical trials for two indications: distal renal tubular acidosis (dRTA) and cystinuria. Listed on both the Euronext Paris and Euronext Brussels stock exchanges, the company is headquartered in Nîmes, France.
© 2020 Advicenne